Acres Commercial Realty Corp. (ACR)
ACRES Commercial Realty: Why We Are Staying Neutral On ACRES Series C Preferred
ACRES Commercial Realty Corp. posted a disappointing Q2 2026, with book value dropping 10% to $26.76/share. Management internalization drove significant one-time costs, with $4.9M in equity compensation and $5.1M in merger expenses impacting net income. The capital structure is unusually preferred-heavy, with $224M in preferred equity versus $189M in common, raising concerns for preferred holders.
ACRES Commercial Realty Corp. (ACR) Q2 2026 Earnings Call Transcript
ACRES Commercial Realty Corp. (ACR) Q2 2026 Earnings Call Transcript
ACRES Commercial (ACR) Reports Q2 Loss, Misses Revenue Estimates
ACRES Commercial (ACR) came out with a quarterly loss of $0.74 per share versus the Zacks Consensus Estimate of $0.11. This compares to earnings of $0.04 per share a year ago.
Implied Volatility Surging for ACRES Commercial Stock Options
Investors need to pay close attention to ACR stock based on the movements in the options market lately.
New Strong Sell Stocks for July 20th
ACR, AEM and AYTU have been added to the Zacks Rank #5 (Strong Sell) List on July 20, 2026.
Acrivon Therapeutics: Priced For Failure, Built For Precision
Acrivon Therapeutics (ACRV) trades below cash value, with the market deeply discounting its platform and pipeline despite promising early data. ACRV's AP3 platform enables precision patient-matching for kinase inhibitor therapies, showing a 50% response rate in serous endometrial cancer with ACR-368. Key near-term catalysts include Phase 2b ACR-368 data and Phase 1 ACR-2316 expansion results, both critical for de-risking and expanding commercial potential.
ACRES Commercial Realty Corp. (ACR) Q1 2026 Earnings Call Transcript
ACRES Commercial Realty Corp. (ACR) Q1 2026 Earnings Call Transcript
ACR.PR.D: A Large Yield From This REIT Preferred Equity
ACRES Commercial Realty has officially entered a definitive agreement to acquire its external manager, ACRES Capital Corp., in an all-stock transaction. This move transitions ACR to being internally managed. The merger is still subject to shareholder approval but would result in a much larger entity with a more diverse set of businesses. The Series D Preferred (ACR.PR.D) remains an attractive target for income-focused investors, sporting a current yield of 9.15%.
ACRES Commercial (ACR) Q1 Earnings Meet Estimates
ACRES Commercial (ACR) came out with quarterly earnings of $0.02 per share, in line with the Zacks Consensus Estimate . This compares to a loss of $0.86 per share a year ago.
Acres Commercial Realty: The High-Yielding Preferred Stock Could Be Interesting
Acres Commercial Realty focuses on first mortgage loans, with 80% of its portfolio backed by multifamily properties, and plans to expand its $2.2B asset base. ACR's preferred shares, particularly Series C, offer a 9.6% yield with floating rates, presenting an attractive risk/reward profile despite a modest dividend coverage ratio. Management's strong track record is evidenced by minimal realized loan losses—just $4.8M on $368M in troubled loans over five years.
ACRES Commercial Realty: Discount To Remain Sticky Given Inflation Expectations
ACRES Commercial Realty trades at a 37% discount to book value, with no dividend but aggressive share buybacks driving shareholder returns. ACR's portfolio is now 81.9% multifamily loans, reducing office exposure and lowering overall risk amid high office vacancy rates. Book value per share grew $0.71 sequentially, aided by buybacks at deep discounts, though no capacity remains on the current program.
ACRES Commercial Realty Corp. (ACR) Q4 2025 Earnings Call Transcript
ACRES Commercial Realty Corp. (ACR) Q4 2025 Earnings Call Transcript
